Yüklüyor......
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are anti-diabetic drugs which improve blood glucose control by blocking reabsorption of glucose from the proximal tubule of kidney. Anti-atherosclerotic properties and cardiovascular protective effects of SGLT2i have been demonstrated by...
Kaydedildi:
| Yayımlandı: | J Clin Med Res |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elmer Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5916538/ https://ncbi.nlm.nih.gov/pubmed/29707091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3392w |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|